Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Viven Solomon
Observed name:
V Solomon
Institution:
Connecticut Children's Medical Center
Observed institution:
Connecticut Children's Medical Center
ORCID:
0009-0001-3544-7182
Observed ORCID:
0009-0001-3544-7182
OpenAlex ID:
A5047657185
Pharmacological and surgical treatment of obesity.
2004
·
P G Shekelle
, S C Morton
, et al.
·
PubMed
·
80
Pharmacological and Surgical Treatment of Obesity: Summary
2004
·
PG Shekelle
, SC Morton
, et al.
·
9
Change from originator infliximab to biosimilar does not affect 1‐year outcome in children with inflammatory bowel disease
2024
·
Viven Solomon
, Sydney Kuzoian
, et al.
·
JPGN Reports
·
2
PDF
Takayasu arteritis in an adolescent with untreated Crohn's disease: A case report
2024
·
Viven Solomon
, Jessica Fennell
, et al.
·
JPGN Reports
·
1
PDF
Tu1817 CHANGE FROM REMICADE® TO INFLIXIMAB BIOSIMILAR DOES NOT AFFECT SHORT-TERM OUTCOME IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE.
2024
·
Viven Solomon
, Sydney Kuzoian
, et al.
·
Gastroenterology
Show more works
View as search
Works count:
5
Citation count:
92
H-index:
2
I10-index:
1
Year
Topic
Type